Brought to you by 
Altana, Pharmacia develop and market roflumilast; deal ends
May 2002
Executive Summary
Altana AG and Pharmacia will jointly develop Altana's respiratory drug roflumilast and market the product in the US and Europe.
Deal Industry
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- R+D and Marketing-Licensing
- Co-Promotion
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com